Hikma Will Push Harder To Make M&A Happen

Executive Chairman And CEO Said Darwazah Talks Strategy Following Fall In Guidance

Following a challenging first half for Hikma, executive chairman and CEO Said Darwazah talks to Generics Bulletin about how the firm is planning to be more active in making deals happen, as well as how it plans to address pressures on its Generics division that led to two consecutive downgrades in guidance this year.

Deal abstract businessmen red white
Sometimes you have to push to make deals happen, Darawazah says • Source: Shutterstock

Speaking to Hikma executive chairman and CEO Said Darwazah immediately after the company reported flat half-year sales and revised down its generics forecasts for the second time this year, the chief executive made clear that the company has a strategy in place to return the company to growth across all three of its business units, including Generics.

Not only that, but Darwazah also set out a bullish approach to deals and M&A, suggesting the firm was ready...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business